SEEG-Tx® is the first FDA-cleared power-controlled radiofrequency ablation system designed specifically for use with DIXI medical SEEG electrodes. It enables clinicians to move directly from localization to intervention within the same SEEG workflow, using electrodes already implanted for diagnostic evaluation. Currently available only in the United States.

SEEG-Tx® is a proprietary radiofrequency ablation system developed by DIXI medical for the treatment of drug-resistant focal epilepsy using implanted DIXI medical SEEG electrodes. Designed to support both diagnostic evaluation and therapeutic intervention, the system enables clinicians to test epileptogenic hypotheses, assess clinical responsiveness, and perform targeted, minimally invasive tissue ablations while maintaining patient interaction throughout the procedure. Unlike conventional radiofrequency ablation systems, SEEG-Tx® incorporates a proprietary power-controlled algorithm that continuously adapts energy delivery according to tissue impedance, ensuring a fully automated and controlled workflow that enhances precision and procedural consistency.